Healthy ExtractsHYEX 54 EBITDA Margin % is -10.74% as of Mar. 2026. GuruFocus rates HYEX with a GF Score™ of 54/100 and a GF Value™ of $1.64 (Fairly Valued). The stock has 2 warning signs investors should review. Among 956 Drug Manufacturers companies, Healthy Extracts ranks worse than 82.32% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Healthy Extracts's EBITDA for the
three
months ended in Mar. 2026 was $-0.17 Mil. Healthy Extracts's Revenue for the
three
months ended in Mar. 2026 was $1.61 Mil. Therefore, Healthy Extracts's EBITDA margin for the quarter that ended in Mar. 2026 was -10.74%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Healthy Extracts EBITDA Margin % Related Terms
Healthy Extracts EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Healthy Extracts's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HYEX vs ZYBT, MRMD, RMTI: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts (HYEX) has a EBITDA Margin % of -10.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthy Extracts and its competitors. According to the industry distribution chart, Healthy Extracts ranks #787 out of 956 companies in the Drug Manufacturers industry, placing it in the top 82.3%.
Is Healthy Extracts' EBITDA Margin % too high?
Healthy Extracts' current EBITDA Margin % is -10.74%. Based on the distribution chart, Healthy Extracts ranks #787 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Healthy Extracts has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' EBITDA Margin % compare to ZYBT and MRMD?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #787 out of 956 companies for EBITDA Margin %. This places Healthy Extracts in the lower half of its industry. The industry median EBITDA Margin % is 12.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.52, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthy Extracts and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthy Extracts's current EBITDA Margin % is -10.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Fairly Valued. The stock's GF Value™ is $1.64, compared to a current price of $1.61 — trading 1.8% below its estimated fair value. The current EBITDA Margin % is -10.74%. Healthy Extracts' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current EBITDA Margin % is -10.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be undervalued.
The current stock price of $1.61 is trading 1.8% below its estimated GF Value™ of $1.64.
GuruFocus considers Healthy Extracts to be Fairly Valued.
Key valuation signals for HYEX:
EBITDA Margin %: -10.74%
GF Value™: $1.64 vs. price of $1.61 (1.8% below fair value)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
54GF Score
Get the complete analysis for HYEX
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
